M
Michelle Berk
Researcher at Stanford University
Publications - 10
Citations - 130
Michelle Berk is an academic researcher from Stanford University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 1 publications receiving 6 citations.
Papers
More filters
Journal ArticleDOI
A systematic review of gut microbiota composition in observational studies of major depressive disorder, bipolar disorder and schizophrenia
Amelia J McGuinness,J. Davis,Samantha L. Dawson,Amy Loughman,Fiona Collier,Martin O'Hely,Carra A Simpson,Jessica Green,Wolfgang Marx,Christopher S Hair,G. Guest,Mahboube Mohebbi,Michelle Berk,D. Stupart,Drake R. Watters,Felice N. Jacka +15 more
TL;DR: In this paper , the authors synthesized the current literature investigating differences in gut microbiota composition in people with the major psychiatric disorders, major depressive disorder (MDD), bipolar disorder (BD), and schizophrenia (SZ), compared to healthy controls.
Journal ArticleDOI
Neurocognitive markers of passive suicidal ideation in late-life depression.
Joshua T. Jordan,Joshua T. Jordan,Christina F. Chick,Christina F. Chick,Camarin E. Rolle,Nathan Hantke,Christine E. Gould,Christine E. Gould,Julie Lutz,Makoto Kawai,Makoto Kawai,Isabelle Cotto,Rosy Karna,Sophia Pirog,Michelle Berk,Keith Sudheimer,Ruth O'Hara,Ruth O'Hara,Sherry A. Beaudreau,Sherry A. Beaudreau +19 more
TL;DR: Findings implicate a neurocognitive signature of PSI: poorer cognitive flexibility and poor inhibitory ability not better accounted for by other domains of cognitive dysfunction and not associated with volumetric differences in the left MFG.
Journal ArticleDOI
Predictors of functional impairment in bipolar disorder: Results from 13 cohorts from seven countries by the global bipolar cohort collaborative
Katherine E. Burdick,Caitlin E. Millett,Anastasia K. Yocum,Cara M. Altimus,Ole A. Andreassen,Valerie Aubin,Raoul Belzeaux,Michelle Berk,Joanna M. Biernacka,Hilary P. Blumberg,Anthony J. Cleare,C. Diaz-Byrd,Caroline Dubertret,Bruno Etain,L. Eyler,Brent P. Forester,J. Fullerton,Mark A. Frye,S Gard,Ophélia Godin,Emmanuel Haffen,Federica Klaus,Trine Vik Lagerberg,Marion Leboyer,Anabel Martínez-Arán,S. McElroy,Philip B. Mitchell,Emilie Olié,Praise Oluwayemisi Olorunfemi,Christine Passerieux,Amy T. Peters,D. L. Pham,Mircea Polosan,Juliana Raush Potter,Martha Sajatovic,Ludovic Samalin,Raymund Schwan,Megan Shanahan,Brisa Solé,Rebecca Strawbridge,Amanda L Stuart,I. Torres,Torill Ueland,Eduard Vieta,Lana J. Williams,Anna Wróbel,Lakshmi N. Yatham,Allan H. Young,Andrew A. Nierenberg,Melvin G. McInnis +49 more
TL;DR: In this paper , the influence of demographic, clinical, and cognitive features on community function in multiple cohorts of well-characterized samples of individuals with bipolar disorder has been investigated and compared.
Posted ContentDOI
Regional, circuit, and network heterogeneity of brain abnormalities in psychiatric disorders
Alexander Segal,Linden Parkes,Kevin M. Aquino,Seyed Mostafa Kia,Thomas Wolfers,Barbara Franke,Martine Hoogman,Christian F. Beckmann,L. Westlye,Ole A. Andreassen,Andrew Zalesky,Bj Harrison,Cristopher Davey,Carles Soriano-Mas,Narcís Cardoner,Jeggan Tiego,M. YuÌcel,Leah Braganza,Chao Suo,Michelle Berk,S Cotton,Mark A. Bellgrove,Andre F. Marquand,Alex Fornito +23 more
TL;DR: In this paper , the authors present a comprehensive, multiscale characterization of individual heterogeneity of brain changes in 1294 cases diagnosed with one of six conditions and 1465 matched healthy controls.
Journal ArticleDOI
A systematic review of interventions in the early course of bipolar disorder I or II: a report of the International Society for Bipolar Disorders Taskforce on early intervention
Aswin Ratheesh,Danielle Hett,J.-P. Ramain,Eileen Wong,Lesley Berk,Philippe Conus,Mary A. Fristad,T R Goldstein,Manon H.J. Hillegers,Sammy Jauhar,L. Kessing,Dj Miklowitz,Greg Murray,Jan Scott,Mauricio Tohen,Lakshmi N. Yatham,Allan H. Young,Michelle Berk,Steven Marwaha +18 more
TL;DR: In this article , the authors conducted a systematic review of the effectiveness of interventions in the early course of bipolar disorder I or II and found that the same pharmacological interventions were more efficacious in preventing recurrences when utilized in earlier rather than later illness course.